Study findings have been published in the Science Direct, Vaccine journal 126998 to assess a double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority and lot-to-lot consistency of single component oral cholera vaccine
Combining homeopathy and biological growth factors, this bio-engineered treatment is a non-invasive, natural, Platelet Rich Plasma treatment and has also been approved by the FDA
